
Eduardo Fonseca discusses XCATH's mission-driven culture and the breakthrough in robotic stroke procedures.
In this episode of DeviceTalks Weekly, Host Tom Salemi explores the breakthrough technologies—and the unique culture—driving one of MedTech's most ambitious missions with XCATH CEO Eduardo Fonseca. Fonseca shares the remarkable story behind XCATH's first remote robotic stroke procedure. Fonseca recounts the years of preparation, the high-stakes operation, and the emotional moment when a patient facing severe disability walked away with what he calls "a second birthday." Along the way, Tom and Eduardo discuss AI's growing role in surgery, the global shortage of stroke specialists, the future of robotic intervention, and why expanding access—not simply advancing technology—is the company's ultimate goal.To learn more about XCATH and talk with Fonseca, join us on July 29 for a live DeviceTalks discussion. Register here for the free webinar. Thank you to our sponsors Confluent, Jabil, Maxon, Solesis, Viant, and VitalPath. MassDevice Editor Chris Newmarker returns to deliver this episode’s Newmarker’s Newsmakers – MDUFA, Corza Medical, Resmed, GTCR, Zimmer Biomet, Pacira Biosciences, and Johnson & Johnson MedTech. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast…
Host: Tom Salemi
Guest: Eduardo Fonseca
Confluent, Jabil, Maxon, Solesis, Viant, VitalPath
Organizations: XCATH, MassDevice, Johnson & Johnson MedTech, Corza Medical, Resmed, GTCR, Zimmer Biomet, Pacira Biosciences
Explore listener stats, chart rankings, contacts and more on the DeviceTalks Podcast Network podcast page.